Pan Cancer T

Pan Cancer T

Foundation date

09/09/2020

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Cell therapy
• #Pharma - Cell therapy

Pan Cancer T is a biotech spin-out that builds further on 20 years of pioneering in adoptive cell therapy developed in the laboratories of Erasmus MC. We intend to lead the fight against solid cancers through T cell receptor (TCR) gene engineered T-cell therapy. Especially, those solid cancers for which there are limited treatment options and a poor prognosis.